Transurethral Resection of the Prostate

European Urology, Supplements

Volumn 8, Issue 6, 2009, Pages 504-512

  Marszalek, Martin ^a   Ponholzer, Anton ^a   Pusman, Marlies ^a   Berger, Ingrid ^a   Madersbacher, Stephan ^a  

^a Donauspital ^*  (Austria)

Author keywords

BPH; Complication; Outcome; Surgery; Technique; TURP

Indexed keywords

STEROID 5ALPHA REDUCTASE INHIBITOR;

ADJUVANT THERAPY; BENIGN PROSTATIC OBSTRUCTION; BLADDER DISEASE; BLADDER NECK STENOSIS; BLADDER STONE; BLADDER TAPENADE; BLEEDING; CLINICAL TRIAL; EJACULATION; EPIDIDYMITIS; HEART INFARCTION; HEMATURIA; HUMAN; INTERMETHOD COMPARISON; LITHOTRIPSY; LOWER URINARY TRACT SYMPTOM; MALE SEXUAL DYSFUNCTION; MICTURITION DISORDER; MORBIDITY; MORTALITY; PERIOPERATIVE COMPLICATION; PEROPERATIVE COMPLICATION; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROSTATECTOMY; QUALITY OF LIFE; REOPERATION; REVIEW; SURGICAL INSTRUMENT; SURGICAL TECHNIQUE; SURGICAL TECHNOLOGY; TRANSURETHRAL RESECTION; TRANSURETHRAL RESECTION SYNDROME; TREATMENT INDICATION; URETHRA STRICTURE; URINARY TRACT INFECTION; URINE FLOW RATE; URINE INCONTINENCE; URINE RETENTION; UROSEPSIS;

EID: 60449088255     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2009.02.003     Document Type: Review

References (31)

1. Madersbacher S., and Marberger M. Is transurethral resection of the prostate still justified?. BJU Int 83 (1999) 227-237
2. Madersbacher S., Alivizatos G., Nordling J., Sanz C.R., Emberton M., and de la Rosette JJMC.H. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46 (2004) 547-554
3. Madersbacher S. Urodynamics prior to prostatectomy: pro. Eur Urol 45 (2004) 557-560
4. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 53 (2008) 68-80
5. Shah T., Palit V., Biyani S., Elmasry Y., Puri R., and Flanigan G.M. Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention. Eur Urol 42 (2002) 329-332
6. Memis A., Ozden C., Ozdal O.L., Guzel O., Han O., and Seckin S. Effect of finasteride treatment on microvessel density in patients with hematuria related to benign prostate hyperplasia. Urol Int 80 (2008) 177-180
7. Madersbacher S., Marszalek M., Lackner J., Berger P., and Schatzl G. The long-term outcome of medical therapy for BPH. Eur Urol 51 (2007) 1522-1533
8. O'Connor R.C., Laven B.A., Bales G.T., and Gerber G.S. Nonsurgical management of benign prostatic hyperplasia in men with bladder calculi. Urology 60 (2002) 288-291
9. Flanigan R.C., Reda D.J., Wasson J.H., Anderson R.J., Abdellatif M., and Bruskewitz R.C. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia. A department of Veterans Affairs Cooperative Study. J Urol 160 (1998) 12-17
10. Vela-Navarrete R., Gonzalez-Enguita C., Garcia-Cardoso J.V., Manzarbeitia F., Sarasa-Corral J.L., and Granizo J.J. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002). BJU Int 96 (2005) 1045-1048
11. Rassweiler J., Teber D., Kuntz R., and Hofmann R. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 50 (2006) 969-980
12. Ho H.S.S., and Cheng C.W.S. Bipolar transurethral resection of prostate: a new reference standard?. Curr Opin Urol 18 (2008) 50-55
13. Lourenco T., Pickard R., Vale L., Grant A., Fraser C., MacLennan G., and Benign Prostatic Enlargement Team. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. BMJ 337 (2008) a449
14. Donohue J.F., Sharma H., Abraham R., Natalwala S., Thomas D.R., and Foster M.C. Transurethral prostate resection and bleeding: a randomized, placebo controlled trial of role of finasteride for decreasing operative blood loss. J Urol 168 (2002) 2024-2026
15. Aagard J., Jonler M., Fuglsig S., Christensen L.L., Jorgensen H.S., and Norgaard J.P. Total transurethral versus minimal transurethral resection of the prostate-a 10-year follow-up study of urinary symptoms, uroflowmetry and residual volume. Br J Urol 74 (1994) 333-336
16. Horninger W., Unterlechner H., Strasser H., and Bartsch G. Transurethral prostatectomy: mortality and morbidity. Prostate 28 (1996) 195-200
17. Madersbacher S., Lackner J., Brössner C., et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 47 (2005) 499-504
18. Reich O., Gratzke C., Bachmann A., et al., Urology section of the Bavarian Working Group for Quality Assurance. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10 654 patients. J Urol 180 (2008) 246-249
19. Mebust W.K., Holtgrewe H.L., Cockett A.T.K., and Peters P.C. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 141 (1989) 243-247
20. Doll H.A., Black N.A., McPherson K., Flood A.B., Williams G.B., and Smith J.C. Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol 147 (1992) 1566-1573
21. Haupt G., Pannek J., Benkert S., Heinrich C., Schulze H., and Senge T. Transurethral resection of the prostate with microprocessor controlled electrosurgical unit. J Urol 158 (1997) 497-501
22. Borboroglu P.G., Kane C.J., Ward J.F., Roberts J.L., and Sands J.P. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 162 (1999) 1307-1310
23. Kuntz R.M., Ahyai S., Lehrich K., and Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate. A randomized prospective trial in 200 patients. J Urol 172 (2004) 1012-1016
24. Wasson J.H., Reda D.J., Bruskewitz R.C., Elinson J., Keller A.M., Henderson W.G., and Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 332 (1995) 75-79
25. Lourenco T., Pickard R., Vale L., et al., Benign Prostatic Enlargement Team. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials. BMJ 337 (2008) a1662
26. Roos N.P., Wennberg J.E., Malenka D.J., et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 320 (1989) 1120-1124
27. Semmens J.B., Wisniewski Z.S., Bass A.J., Holman C.D.J., and Rouse I.L. Trends in repeat prostatectomy after surgery for benign prostate disease: application of record linkage to healthcare outcome. BJU Int 84 (1999) 972-975
28. Wasson J.H., Bubolz T.A., Lu-Yao G.L., Walker-Corkery E., and Hammond C.S. Transurethral resection of the prostate among Medicare beneficiaries: 1984 to 1997. J Urol 164 (2000) 1212-1215
29. Hahn R.G., Farahmand B.Y., Hallin A., Hammar N., and Persson P.G. Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy. Urology 55 (2000) 236-240
30. Shalev M., Richter S., Kessler O., Shpitz B., Fredman B., and Nissenkorn I. Long-term incidence of acute myocardial infarction after open and transurethral resection of the prostate for benign prostatic hyperplasia. J Urol 161 (1999) 491-493
31. Holman C.D.J., Wisniewski Z.S., Semmens J.B., Rouse I.L., and Bass A.J. Mortality and prostate cancer risk in 19 598 men after surgery for benign prostatic hyperplasia. BJU Int 84 (1999) 37-42